Diffusion Pharmaceuticals Inc. ( (DFFN) News Headlines

▮ More

Date

Headline

7/23/2019 8:43:35 AM Diffusion Reports Favorable Safety Data For Dose-Escalation Run-in Of Phase 3 INTACT Study

5/21/2019 9:28:08 PM 5 Top Gainers In Pharma Sector (ARRY, EQ, ARWR...)

5/2/2019 9:00:32 PM 6 Top Gainers In Pharma Sector (DFFN, QTNT, ORGO...)

4/25/2019 9:00:16 PM 7 Top Gainers In Healthcare Sector (TLSA, SWAV, CPRX...)

3/7/2019 10:20:55 PM 9 Top Gainers In Healthcare Sector (BPTH, ARQL, SEEL…)

3/6/2019 7:53:47 PM 6 Top Gainers In Healthcare Sector (BPTH, OHRP, PRTO...)

2/27/2019 9:50:54 PM 6 Top Gainers In Healthcare Sector (TNDM, MGTX, TCRR...)

12/17/2018 9:57:16 AM US Patent Office Awards Diffusion Rights For Use Of TSC In Conjunction With Only FDA-Approved Stroke Therapeutic

11/14/2018 9:06:44 AM Diffusion Pharma Q3 Loss/shr $0.13 Vs. EPS $0.20 Prior Year

9/12/2018 9:05:01 AM FDA Oks Start Of Innovative On-Ambulance Phase 2 Trial For Treatment Of Acute Stroke By Diffusion Pharma

8/13/2018 8:34:57 AM Diffusion Pharma H1 Net Cash Used In Operating Activities $5.8 Mln Vs $6.2 Mln Last Year

6/12/2018 8:43:54 AM Diffusion Pharma Announces Validation Of European Patent For Oral Formulations Of TSC

2/1/2018 8:15:43 AM Diffusion Announces Allowances Of Two U.S. Patent Applications

1/30/2018 12:51:58 AM ARDM Chokes, ABEO On Track, MASI Gets FDA Nod, ALBO Up 50% YTD

1/18/2018 6:01:52 AM Diffusion Pharma Prices Underwritten Public Offering Of 15 Mln Common Shares At $0.80/Shr

1/10/2018 9:37:02 PM ALRN To Report Data In 1H18, DFFN On Watch, D-Day Awaits ARDM

1/10/2018 8:52:20 AM Orphan Rare Diseases R&D Advancements Increase Novel Therapeutic Options For Drug Development Pipeline

1/9/2018 9:57:54 AM Diffusion Pharmaceuticals Inc. (DFFN) Has Spiked To The Upside

Older Articles